Search

close   X

Lubna Mehyar, MD

dr. mehyar headshot
star star star star star

57 ratings
10 comments

pronouns: She\Her\Hers

expertise

general pediatric hematology and oncology, bone marrow transplant and bone marrow failure

bio

Dr. Lubna Mehyar is a board-certified pediatric hematologist and oncologist at Dayton Children's Hospital. Prior to coming to Dayton Children's, Dr. Mehyar spent several years at West Virginia University as a member of their pediatric hematology and oncology faculty. 

Dr. Mehyar received her medical degree from Jordan University of Science and Technology in Irbid, Jordan. She has completed two residencies, a pediatric hematology oncology fellowship and a pediatric bone marrow transplant fellowship.  Dr. Mehyar has presented, published and participated in over 25 different projects and publications. And in 2020, Dr. Mehyar was voted a Women in Medicine Top America's Doctors for pediatric hematology, oncologist and bone marrow transplant physician. 

When asked why she chose her specialty, Dr. Mehyar says "Nothing else gave me the satisfaction I felt when I managed this subset of patients. I wanted to be a part of this challenging field with ongoing research and ground-breaking development. I longed to be part of something in which change for the better is a realistically attainable goal."

other languages spoken: 

  • Arabic

Scheduling in-person appointments for new patients only.

If your child is an existing patient, log in to MyKidsChart to schedule directly with your provider for follow up care.

schedule an appointment

education and training

  • medical school: Jordan University of Science and Technology
  • internship: Jordan Hospital
  • residency: (1) The Hospital of University of Jordan, (2) University of Medicine and Dentistry of New Jersey (UMDNJ)
  • fellowship: (1) University Hospitals Rainbow Babies and Children's Hospital, (2) Nationwide Children's Hospital
  • board certification: pediatric hematology/oncology, general pediatrics

publications and presentations

peer reviewed journal articles/abstracts

  1. Bhunia N, Abu-Arja R, Stanek J , Mehyar LS , Shaw P , Jin Kang H , Stein J , O'Brien T , Roberts C , Chi-Wai Lee A , Loeb D , Ozkaynak M , Dalal J , Strahlendorf C, Goyal R, Shenoy S, Rangarajan H. A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders. Transfusion. 2021 Mar;61(3):894-902. doi: 10.1111/trf.16260. Epub 2021 Jan 21.
  2. Mehyar LS, Kraft M, Prince B, Reshmi S, Abraham R, Abu-Arja R. Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 1. J Clin Immunol. 2021 Feb 5;1-6. doi: 10.1007/s10875-021-00984-x.
  3. Mehyar LS, Abu-Arja MH, Stanek JR, Elbeshlawi I, AbdelBaki MS. The Risk of Developing Secondary Central Nervous System Tumors After Diagnostic Irradiation From Computed Tomography in Pediatrics: A Literature Review. Pediatr Neurol. 2019 Sep;98:18-24. doi: 10.1016/j.pediatrneurol.2019.03.028. Epub 2019 Apr 5. Review; PMID:31235364
  4. Mehyar, L. S. Rolla Abu Arja, Hemalatha G. Rangarajan, Vinita Pai, Dennis W. Bartholomew. Matched unrelated donor transplantation in glycogen storage disease type 1b patient corrects severe neutropenia and recurrent infections. Bone Marrow Transplant. (2018). doi:10.1038/s41409-018-0147-z
  5. Gonzales A, Gates E, Bhunia N, Mehyar L, Hashem H, Stanek JR, Krebs B, Auletta JJ. Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 May 11. pii: S1083-8791(19)30288-5. doi: 10.1016/j.bbmt.2019.05.004. PMID:31085304
  6. Souayah N, Mehyar L, Khan HM, Yacoub HA, Abed Al-Kariem A Al-Qudah Z, Nasar A, Begum Sheikh Z, Maybodi L, Qureshi AI. Trends in outcome and hospitalization charges of adult patients admitted with botulism in the United States. Neuroepidemiology. 2012 Apr;38(4): 233-236. Cited in PubMed; PMID: 22555681.
  7. Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).J Clin Neuromuscul Dis. 2012 Dec;14(2):66-71. Cited in Pubmed; PMID: 23172385.

book chapters

  1. Mehyar L, Chapter 27: What Pediatricians Need to Know About Acquired Aplastic Anemia. Book title: Benign Hematologic Disorders in Children: A Clinical Guide. 2020. Springer Nature ISBN 978-3-030-49979-2.

poster presentations

  1. Dagmar Berghuis, Lisanne van Leeuwen, Jorinde Hoogenboom, Corry Weemaes, Mary Slatter, Reem Elfeky, Michael Albert, Roland Meisel, Alexandra Laberko, Akif Yesilipek, Lubna Mehyar, Andrew Gennery, Arjan Lankester, on behalf of the EBMT Inborn Errors Working Party (EBMT-IEWP) and Stem Cell Transplant for primary Immune Deficiencies in Europe (SCETIDE) Immunodeficiency – centromeric instability – facial dysmorphism (ICF) syndrome: evaluation of characteristics and outcome after allogeneic hematopoietic stem cell transplantation. EBMT Annual meeting, Madrid/Spain August 31st, 2020
  2. Anne Gonzales, Erin Gates, Lubna Mehyar, Joseph R Stanek, Hasan Hashem; Bonnie Krebs, Jeffery Auletta .Transplant Energize Me Patient Outcome (TEMPO): Improving Patient Functional Mobility and Reducing Resource Utilization during Hematopoietic Cell Transplantation. Poster presented at: ASBMT Annual meeting February 25, 2017, Salt Lake City/Utah.
  3. Mehyar L, Meyerson H, Caimi P, Dallas M, Dalal J, Fu P, Letterio J.J. Role of Cdk5 in acute graft versus host disease after allogeneic hematopoietic stem cell transplant: correlation with diagnosis and severity, prediction of survival. Poster presented at: ASBMT Annual meeting February 25, 2017, Salt Lake City/Utah.
  4. Mehyar L, Hashem H, Pateva I, De Blank P, Dalal J. Enterococcus as an Infectious Trigger for Hemophagocytic Lymphohistiocytosis (HLH) in AML Patients Post-Allogeneic Hematopoietic Stem Cell Transplant (HSCT). Poster presented at: ASBMT Annual meeting February 18, 2016, Honolulu, Hawaii.
  5. Abu-Arja M, Mehyar L, Finley J. Hepatotoxicity during Induction chemotherapy, with or without high-dose methotrexate (HD-MTX), on the Head Start II trial for primary central nervous system (CNS) tumors Poster presented at: ISPNO, Denver 2018
  6. Mehyar L, Attia W, Monteiro I. Ewing Sarcoma (ES) In A Child With Ulcerative Colitis (UC). Poster presented at: NASPGHAN Annual Meeting, October 11, 2013, Chicago, IL.
  7. Mehyar, L., Krivitskaya, N., Khan, H., Islam, S., Nasar, A., Lee, H., Yacoub, H., Souayah, N. / Mehyar, L. (2010, April). The Occurrence of Central Nervous System Demyelination in Diabetes. Poster presented at: 62nd American Association of Neurology Meeting; Ontario, Canada.
  8. Mehyar, L.,Khan H., Al-Qudah, Z., Islam, S., Souayah,N./Mehyar,L. (2010, April). Trends in Outcomes and Hospitalization Costs of Infantile Botulism in United States. Poster presented at: 62nd American Association of Neurology Annual Meeting; Ontario, Canada.
  9. Souayah N, Mehyar L, Khan HM, Yacoub HA, Abed Al-Kariem A Al-Qudah Z, Nasar A, Begum Sheikh Z, Maybodi L, Qureshi AI. Trends in outcome and hospitalization charges of adult patients admitted with botulism in the United States. Neuroepidemiology. 2012 Apr;38(4): 233-236. Cited in PubMed; PMID: 22555681.
  10. Al-Qudah, Z.,Mehyar, L., Khan, H., Souayah, N./Al-Qudah, Z. (2010, October). Trends in Outcomes and Hospitalization Charges in Inflammatory Myopathies. Poster presented at: 57th Annual Meeting of AANEM; Quebec, Canada.
  11. Al-Qudah, Z.,Mehyar, L., Krivitskaya, N., Khan, H., Islam, S., Baker, B., Souayah, N./Yacoub, H. (2010, April). The Prevalence and Effect of Diabetes on the Course of Amyotrophic Lateral Sclerosis. Poster presented at: 62nd American Association of Neurology Meeting; Ontario, Canada.
  12. Khan, H., Mehyar, L., Saulat, B., Islam, S., Souayah N., Yacoub, H.. (2010, April). Trends in Outcomes and Hospitalization Costs among Patients with Warding's Hoffman Disease in the United States.  Poster presented at: 62nd American Association of Neurology Meeting; Ontario, Canada.
  13. Khan, H., Yacoub, H., Farhad, F., Mehyar, L., Islam,S., Saulat, B., Abou Elenein, R., Souayah, N./Yacoub, H. (2010, October). Trends in Outcome and Hospitalization Cost Among Adult Patients with Acute Ischemic Stroke in the United States. Poster presented at: 62nd American Association of Neurology Annual Meeting; Ontario, Canada.
  14. Samizadeh, M., Farhad, K., Mehyar, L., Khan, H., Souayah,/Souayah, N.. (2010, April). Trends in Outcomes and Hospitalization Costs among Pediatric Spinal Cord Injury Patients in the United States. Poster presented at: 62nd American Association of Neurology Meeting.; Ontario, Canada.
  15. Saulat,B., Mehyar, L.,Khan H., Abou Elenein R., Souayah N./Mehyar L. (2010, April). Trends in Outcomes and Hospitalization Cost of Adult Patients with Botulism in the United States. Poster presented at: 62nd American Association of Neurology Annual Meeting; Ontario, Canada.
  16. Yacoub, H., Khan, H., Mehyar, L., Islam,S., Souayah, N./Yacoub, H. (2010, April). Guillain-Barre Syndrome after Influenza Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System.(1990-2009). Poster presented at: 62nd American Association of Neurology Annual Meeting; Ontario, Canada.

oral presentations

  1. Mehyar, L Immunedeficiency, Centromere instability and Facial dysmorphism type 1 ICF-1).Primary Immune Deficiency Treatment Consortium (PIDTC) Eight Annual Scientific Workshop, May 8th, 2018 Philadelphia, PA
  2. Mehyar, L. Role of Cdk5 in Acute Graft versus Host disease (aGVHD). Fellows science day, Cleveland, OH.
  3. Souayah, N., Mehyar, L., Baker, N., Levison, S./Souayah, N. (2010, April). Radiation Sensitivity of Neural and Progenitor Stem Cells. Oral Presentation presented at: 62nd American Association of Neurology Annual Meeting; Ontario, Canada.

honors and awards

  • 2014 - Nominated for Golden Apple teaching award
  • 2016 - Faculty Research Award Program (FRAP)
  • 2020 - Women in Medicine top America’s doctors- Pediatric Hematologist, Oncologist and bone marrow transplant physician
  • 2020-2021 - Pediatric Hematology Oncology Teaching Liaison
ratings and reviews

Question Rating Breakdown

star star star star star

Provider Rating

Distribution

5

 

10 comments

4

 

0 comments

3

 

0 comments

2

 

0 comments

1

 

0 comments

Comments

star star star star star

We had a 4:30 appointment and didn't get called back until 5:15ish....but they explained MULTIPLE times and apologized over and over again. We understand emergency's happen, and the employees were very apologetic and cared up our time. We love Dayton Children's and were not upset about the wait time.

star star star star star

Dr. Mehyar and her resident were very easy to talk to. They took the time to sit and listen to my concerns. They were also great with my daughter, taking things at a slow pace not to overwhelm her. The doctor even called at the end of the day to go over lab results. I greatly appreciate all of their time!

star star star star star

Yeah, I almost can't put into words how well she has treated me and my son. I had a scare earlier today to where I thought he had leukemia by the way one of the tests read. So I came to the hospital and the doctor and actually the administrator of the hematology oncology group there actually took time to meet with me and my son without an appointment to explain things and made me feel better because my son did not have leukemia. So needless to say, I'm

star star star star star

Yes, she was very supportive, very detailed, oriented in regards to my child's well-being and the things that's going on with her health. She explained, very informative on everything and helping us out a lot, even with detailed information of things that could and could not be part of it. I truly appreciate her and her going over and beyond. Thank you.

Load more testimonials...

view all doctors